Virtu Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-32,815	Closed	-$700K	–	1588
2025 Q3	$700K	Buy	+32,815	New	+$776K	0.04%	442
2024 Q3	–	Sell	-14,712	Closed	-$239K	–	1307
2024 Q2	$239K	Sell	14,712 -700	-5%	-$11.3K	0.02%	654
2024 Q1	$285K	Buy	+15,412	New	+$382K	0.02%	633
2022 Q3	–	Sell	-15,354	Closed	-$216K	–	1666
2022 Q2	$216K	Buy	+15,354	New	+$287K	0.02%	730
2022 Q1	–	Sell	-44,980	Closed	-$1.05M	–	1440
2021 Q4	$1.05M	Buy	+44,980	New	+$905K	0.11%	182
2021 Q3	–	Sell	-47,189	Closed	-$1.15M	–	1440
2021 Q2	$1.15M	Buy	+47,189	New	+$1.07M	0.11%	166
2020 Q3	–	Sell	-12,285	Closed	-$595K	–	988
2020 Q2	$595K	Buy	+12,285	New	+$590K	0.07%	315
2019 Q4	$881K	Sell	20,601 -25,513	-55%	-$1.11M	0.09%	257
2019 Q3	$1.66M	Buy	+46,114	New	+$1.4M	0.13%	148
2019 Q2	–	Sell	-18,727	Closed	-$503K	–	1416
2019 Q1	$503K	Sell	18,727 -4,248	-18%	-$99.2K	0.04%	557
2018 Q4	$372K	Buy	+22,975	New	+$446K	0.03%	623